Under construction – not a live service
Sign in
Taking people in United StatesPhase 2

Testing butyrate enemas in children with ulcerative colitis

Tests butyrate enemas in children with ulcerative colitis, a bowel disease.

Plain-language title generated from the registry record
Registry title: The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

Key facts

Where
Los Angeles, United StatesSee the site
Phase
Phase 2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 7 and 21 years old?

Source: NCT05218850, who can take part

Where in United States

  • Children's Hospital Los AngelesLos Angeles, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Children's Hospital Los Angeles
Trial code
NCT05218850
Record updated
4 June 2026
Original description
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.Read full original descriptionShow less

Butyrate Therapy in Hispanic Children With Ulcerative Colitis

Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.

Inclusion: 7-21 years, mild to moderate ulcerative colitis.

Exclusion: UC therapy within 4 weeks of study medication initiation; infectious colitis, -pregnancy.

ClinicalTrials.gov NCT05218850